The recent identification of PZH’s modulation of the EGFR/JAK1/STAT3 pathway enhances its known inhibitory effects on the TGF-β1/Smad2 axis, thereby elucidating a multifaceted mechanism against hepatic fibrosis. Here, STAT3 is linked to Hepatic fibrosis.